Thomas V. Inglesby
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Thomas V. Inglesby has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Donald A. Henderson
3 shared publicationsTara O'Toole
2 shared publicationsA D Fine
1 shared publicationA M Friedlander
1 shared publicationArthur M. Friedlander
1 shared publicationD A Henderson
1 shared publication
Latest Publications
- Top Cited Papers
- 1 May 2002
- Published by American Medical Association (AMA) in JAMA
- Vol. 287 (17) , 2236-2252
Anthrax as a Biological Weapon, 2002
ObjectiveTo review and update consensus-based recommendations for medical and public health professionals following a Bacillus anthracis attack against a civilian population.ParticipantsThe working group included 23 experts from academic medical centers, research organizations, and governmental, military, public health, and emergency management institutions and agencies.EvidenceMEDLINE databases were searched from January 1966 to January 2002, using the Medical Subject Headings anthrax, Bacillus anthracis, biological weapon, biological terrorism, biological warfare, and biowarfare. Reference review identified work published before 1966. Participants identified unpublished sources.Consensus ProcessThe first draft synthesized the gathered information. Written comments were incorporated into subsequent drafts. The final statement incorporated all relevant evidence from the search along with consensus recommendations.ConclusionsSpecific recommendations include diagnosis of anthrax infection, indications for vaccination, therapy, postexposure prophylaxis, decontamination of the environment, and suggested research. This revised consensus statement presents new information based on the analysis of the anthrax attacks of 2001, including developments in the investigation of the anthrax attacks of 2001; important symptoms, signs, and laboratory studies; new diagnostic clues that may help future recognition of this disease; current anthrax vaccine information; updated antibiotic therapeutic considerations; and judgments about environmental surveillance and decontamination.
- 1 May 2002
- Published by American Medical Association (AMA) in JAMA
- Vol. 287 (17) , 2236-2252
Top Cited PapersAnthrax as a Biological Weapon, 2002
ObjectiveTo review and update consensus-based recommendations for medical and public health professionals following a Bacillus anthracis attack against a civilian population.ParticipantsThe working group included 23 experts from academic medical centers, research organizations, and governmental, military, public health, and emergency management institutions and agencies.EvidenceMEDLINE databases were searched from January 1966 to January 2002, using the Medical Subject Headings anthrax, Bacillus anthracis, biological weapon, biological terrorism, biological warfare, and biowarfare. Reference review identified work published before 1966. Participants identified unpublished sources.Consensus ProcessThe first draft synthesized the gathered information. Written comments were incorporated into subsequent drafts. The final statement incorporated all relevant evidence from the search along with consensus recommendations.ConclusionsSpecific recommendations include diagnosis of anthrax infection, indications for vaccination, therapy, postexposure prophylaxis, decontamination of the environment, and suggested research. This revised consensus statement presents new information based on the analysis of the anthrax attacks of 2001, including developments in the investigation of the anthrax attacks of 2001; important symptoms, signs, and laboratory studies; new diagnostic clues that may help future recognition of this disease; current anthrax vaccine information; updated antibiotic therapeutic considerations; and judgments about environmental surveillance and decontamination.
- Open Access
- 1 February 2001
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 32 (3) , 436-445
A Plague on Your City: Observations from TOPOFF
The United States Congress directed the Department of Justice to conduct an exercise engaging key personnel in the management of mock chemical, biolo
- 1 February 2001
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 32 (3) , 436-445
Open AccessA Plague on Your City: Observations from TOPOFF
The United States Congress directed the Department of Justice to conduct an exercise engaging key personnel in the management of mock chemical, biolo
- Open Access
- 1 June 2000
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 30 (6) , 926-929
Preventing the Use of Biological Weapons: Improving Response Should Prevention Fail
This article presents an overview of the nature and scope of the challenges posed by biological weapons, and offers ways by which the infectious diseases professional community might address the challenges of biological weapons and bioterrorism.
- 1 June 2000
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 30 (6) , 926-929
Open AccessPreventing the Use of Biological Weapons: Improving Response Should Prevention Fail
This article presents an overview of the nature and scope of the challenges posed by biological weapons, and offers ways by which the infectious diseases professional community might address the challenges of biological weapons and bioterrorism.
- Top Cited Papers
- 3 May 2000
- Published by American Medical Association (AMA) in JAMA
- Vol. 283 (17) , 2281-2290
Plague as a Biological Weapon
ObjectiveThe Working Group on Civilian Biodefense has developed consensus-based recommendations for measures to be taken by medical and public health professionals following the use of plague as a biological weapon against a civilian population.ParticipantsThe working group included 25 representatives from major academic medical centers and research, government, military, public health, and emergency management institutions and agencies.EvidenceMEDLINE databases were searched from January 1966 to June 1998 for the Medical Subject Headings plague, Yersinia pestis, biological weapon, biological terrorism, biological warfare, and biowarfare. Review of the bibliographies of the references identified by this search led to subsequent identification of relevant references published prior to 1966. In addition, participants identified other unpublished references and sources. Additional MEDLINE searches were conducted through January 2000.Consensus ProcessThe first draft of the consensus statement was a synthesis of information obtained in the formal evidence-gathering process. The working group was convened to review drafts of the document in October 1998 and May 1999. The final statement incorporates all relevant evidence obtained by the literature search in conjunction with final consensus recommendations supported by all working group members.ConclusionsAn aerosolized plague weapon could cause fever, cough, chest pain, and hemoptysis with signs consistent with severe pneumonia 1 to 6 days after exposure. Rapid evolution of disease would occur in the 2 to 4 days after symptom onset and would lead to septic shock with high mortality without early treatment. Early treatment and prophylaxis with streptomycin or gentamicin or the tetracycline or fluoroquinolone classes of antimicrobials would be advised.
- 3 May 2000
- Published by American Medical Association (AMA) in JAMA
- Vol. 283 (17) , 2281-2290
Top Cited PapersPlague as a Biological Weapon
ObjectiveThe Working Group on Civilian Biodefense has developed consensus-based recommendations for measures to be taken by medical and public health professionals following the use of plague as a biological weapon against a civilian population.ParticipantsThe working group included 25 representatives from major academic medical centers and research, government, military, public health, and emergency management institutions and agencies.EvidenceMEDLINE databases were searched from January 1966 to June 1998 for the Medical Subject Headings plague, Yersinia pestis, biological weapon, biological terrorism, biological warfare, and biowarfare. Review of the bibliographies of the references identified by this search led to subsequent identification of relevant references published prior to 1966. In addition, participants identified other unpublished references and sources. Additional MEDLINE searches were conducted through January 2000.Consensus ProcessThe first draft of the consensus statement was a synthesis of information obtained in the formal evidence-gathering process. The working group was convened to review drafts of the document in October 1998 and May 1999. The final statement incorporates all relevant evidence obtained by the literature search in conjunction with final consensus recommendations supported by all working group members.ConclusionsAn aerosolized plague weapon could cause fever, cough, chest pain, and hemoptysis with signs consistent with severe pneumonia 1 to 6 days after exposure. Rapid evolution of disease would occur in the 2 to 4 days after symptom onset and would lead to septic shock with high mortality without early treatment. Early treatment and prophylaxis with streptomycin or gentamicin or the tetracycline or fluoroquinolone classes of antimicrobials would be advised.